The effect of combined supplementation with vitamin D and omega-3 fatty acids on blood glucose and blood lipid levels in patients with gestational diabetes.

What Was Tested

This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.

To investigate the effects of vitamin D and omega-3 fatty acids on glucose and blood lipid metabolism in gestational diabetes (GDM) women.

The t-test was used to compare the differences between groups, and the chi-square test was used to assess percentage differences.

Who Took Part

The abstract describes 150 patients taking part.

PubMed tags the participants as women only.

A total of 150 patients with GDM aged 18-40 who were admitted to their hospital from May 2019 to December 2020 were enrolled in this study.

The subjects were divided into test and control groups according to whether they took vitamin D and omega-3 fatty acids.

How the Study Was Run

In design terms this was a randomized study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Repeated measures variance was used to analyze the effects of vitamin D and omega-3 fatty acids on insulin metabolism markers and blood lipid profiles.

What Was Measured

Topics PubMed links to this paper include Blood Glucose, Diabetes, Gestational, Dietary Supplements, Fatty Acids, Omega-3, Lipids and Vitamin D.

The authors tagged it with the keywords gestational diabetes (GDM) and omega-3 fatty acids.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 150 patients.

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2021 (Annals of palliative medicine), a journal based in China.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.